afternoon welcome agilent technology fourth quarter earn conference call name operator today call operator instruction like introduce host today call vice president investor relation please ahead vice president investor relation thank welcome everyone agilent fourth quarter conference call fiscal year agilent president agilent senior vice president join comment president agilent life science apply market group president agilent diagnostics genomics group president agilent group presentation webcast live news release investor presentation information supplement today discussion along record webcast make available website investor agilent today comment refer financial measure find directly comparable financial metric reconciliation website unless otherwise note reference increase decrease financial metric year year reference revenue growth core basis core revenue growth exclude impact currency acquisition divestiture complete within past month guidance base exchange rate also make forward look statement financial performance company statement subject risk uncertainty valid today company assume obligation update please look company recent file complete picture risk factor like turn call president chief executive thank everyone join call today agilent deliver another excellent quarter close outstanding record billion fiscal revenue almost billion higher last year full year core growth grow last year strength broad base three business unit grow core year full year operate margin basis point earn share take closer look strong finish review result momentum continue order increase faster revenue time deliver fourth straight quarter double digit revenue growth billion revenue report basis core revenue grow exceed expectation core growth last year operate margin basis point last year year year earn growth also exceed expectation continue perform extremely pharma largest market grow drive biopharma business total pharma represent overall revenue compare revenue year strong growth chemical energy business continue deliver growth quarter grow last year number positive expect chemical energy continue strong growth trajectory fiscal diagnostics clinical revenue grow grow last year test volume start recover geographic basis result lead strong performance business grow last year grow core strong growth last year order growth outpace revenue growth third quarter look performance business unit life science apply market group generate revenue million report core basis growth broad base lead strength liquid chromatography cell analysis pharma chemical energy market particularly strong instrument purchase cell analysis business cross million revenue mark quarter first time quarter announce high mobility enhancement automation software suite receive offer improve analysis protein peptide speed development protein base therapeutic agilent group post revenue million report core growth broad base drive strength service contract demand service chemistry supply focus increase connect rate continue strong expansion base increase connect rate bode continue strengthen business move forward ability drive growth leverage scale produce operate margin roughly basis point prior year diagnostics genomics group deliver revenue million report core oligo business lead robust double digit growth quarter achieve full year revenue exceed million expect another year strong double digit growth continue great increase throughput exist capacity expansion train oligo manufacture facility proceed plan expect additional capacity come online calendar year move business group update several significant development agilent quarter announce commitment achieve zero greenhouse emission believe approach deliver rigorous sustainability apply everything else also believe action right thing fundamental achieve long term success sustainable leadership continue primarily recognize investor business daily recently name agilent company list also company diversity inclusion represent company priority core element culture quarter achieve recognition world best employer best workplace woman agilent strong track record deliver market growth lead customer satisfaction always look accelerate growth strengthen focus customer implement agilent commercialization combine first time customer face activity leader organization bring together strengthen sale market digital channel service enterprise level commercialization lead continue lead agilent group business group president agilent first ever chief commercial officer like characterize move double success achieve apply holistic customer focus approach aspect business also move chemistry supply division close organizational alignment instrument chemistry development accelerate progress instrument connect rate chemistry consumables believe structure follow strategy organizational structure enhance customer focus execution growth strategy look ahead come year strong position continue deliver build growth strategy agilent business remain strong enter year robust backlog multiple growth driver couple prove execution excellence agilent year agilent investor raise long term annual growth outlook range reaffirm commitment annual operate margin improvement double digit growth year achieve long term goal provide detail fiscal initial full year guide call core growth range expect continue line growth launch market lead product service invest grow business deliver outstanding customer service confidence unstoppable agilent ability execute deliver remain firmly intact formula deliver solid financial result outstanding shareholder return continue strong growth please performance satisfy tell agilent best come customer shareholder thank call today look forward question hand call senior vice president chief financial good afternoon everyone remark today provide additional detail revenue take income statement financial metric finish initial outlook upcoming year first quarter unless otherwise note remark focus result mention strong result fourth quarter revenue billion reflect report growth detail want acknowledge supply chain great manage challenge global environment core revenue growth point guidance range currency account growth contribute half point growth expect relate revenue roughly flat sequentially result point headwind quarterly revenue growth late quarter transit time certain case greater anticipate result revenue defer result drive continuation outstanding momentum pharma biopharma particular chemical energy diagnostics clinical also deliver strong result largest market pharma grow quarter tough compare last year small molecule segment deliver teen growth large molecule grow pharma standout year grow full year grow expect pharma business grow high single digit chemical energy continue show strength grow instrument growth teen quarter impressive performance increase last year business grow year decline growth drive continue momentum chemical engineer material expect business continue grow solidly next year high single digit diagnostics clinical grow three group grow nicely quarter largest dollar contributor market drive pathology relate business business continue penetrate clinical market drive growth strong performance cell analysis mass spec teen growth strong growth albeit small base year diagnostics clinical business grow year decline slightly expect continue grow high single digit academia government lumpy represent business versus flat growth last year research continue remain open globally increase capacity pandemic level come single digit roughly flat year grow decline last year expect market continue improve slightly fiscal year expect growth single digit food flat quarter tough compare grow decline year food grow grow look forward expect food return historical growth rate single digit round market environmental forensics decline fourth quarter decline last year growth environmental decline forensics year grow decline look forward like food expect environmental forensics grow single digit come year agilent overall geographic basis region grow lead grow grow year lead growth follow turn rest fourth quarter gross margin basis point year gross margin performance along continue operate expense leverage result operate margin fourth quarter improve basis point last year together deliver versus last year quarter benefit additional save result quarterly rate full year rate share count million share expect year come increase continue strong cash flow generation result million quarter increase versus last year generate almost billion operate cash invest million capital expenditure quarter return million shareholder million dividend repurchase roughly share million year return billion shareholder form dividend share repurchase year billion cash billion outstanding debt leverage ratio time great outstanding year move outlook fiscal still deal pandemic additional challenge around logistics inflationary pressure enter year strong backlog momentum full year expect revenue range billion billion represent report growth core growth consistent long range goal incorporate absorb roughly headwind associate relate revenue majority impact come expect three business grow lead expect grow high single digit continue contribution cancer diagnostics expect grow high single digit service chemistry supply business grow comparably expect grow single digit expect operate margin expansion basis point year absorb build train site help build model plan rate consistent current policy million fully dilute share outstanding translate fiscal expect share result double digit growth finally expect operate cash flow approximately billion billion capital expenditure million capital investment represent increase continue focus growth bring train expansion online expand consumables manufacture capacity cell analysis genomics business also announce raise dividend continue important streak dividend increase provide another source value shareholder move first quarter guidance specific additional context year year shift last year result expect revenue shift second quarter year customer shut ahead holiday addition mention expect largest impact relate revenue headwind first quarter estimate factor impact base business growth point roughly equal impact expect revenue range billion billion represent report core growth adjust time year relate headwind core growth would roughly quarter first quarter earn expect range couple additional point open call question conjunction agilent commercial organization talk report structure start addition provide recast certain historical financials account segment change file annual report form extremely proud agilent achieve look forward another strong performance back vice president investor could please provide instruction